Literature DB >> 23273403

Recombinant thrombomodulin improves the visceral microcirculation by attenuating the leukocyte-endothelial interaction in a rat LPS model.

Toshiaki Iba1, Koichiro Aihara, Shin Watanabe, Youichi Yanagawa, Masaaki Takemoto, Atsushi Yamada, Daphne Yang.   

Abstract

INTRODUCTION: Abnormalities in vascular endothelial function play an important role in the development of septic organ dysfunction. The aim of this study was to examine the effect of recombinant thrombomodulin (rTM) on leukocyte-endothelial interaction and subsequent malcirculation in endotoxemia.
MATERIALS AND METHODS: Wistar rats were administered with either low, medium or high dose of rTM (n=7 each) 2hours after lipopolysaccharide (LPS) infusion. Mesenteric microcirculation after the treatment was observed under the intravital microscopy. In another series (n=5 each), plasma levels of high-mobility group box 1 (HMGB1) levels were measured at 5hours after LPS infusion.
RESULTS: Microscopic findings revealed suppression in leukocyte adhesion, thrombus formation and endothelial damage with the treatment by rTM. However, high-dose rTM tended to increase the bleeding events. Thus, blood flow was better maintained with medium-dose rTM (P<0.05). The increase in HMGB1 level was significantly suppressed by medium and high-dose rTM (P<0.05, respectively).
CONCLUSIONS: rTM demonstrated a protective effect on microcirculation through the inhibition of leukocyte-endothelial interaction and suppression of HMGB1.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23273403     DOI: 10.1016/j.thromres.2012.11.025

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  5 in total

Review 1.  Thrombotic Regulation From the Endothelial Cell Perspectives.

Authors:  Miao Wang; Huifeng Hao; Nicholas J Leeper; Liyuan Zhu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-06       Impact factor: 8.311

2.  The effects of sepsis on endothelium and clinical implications.

Authors:  Elena V Dolmatova; Keke Wang; Rohan Mandavilli; Kathy K Griendling
Journal:  Cardiovasc Res       Date:  2021-01-01       Impact factor: 10.787

3.  HMGB1: A Promising Therapeutic Target for Prostate Cancer.

Authors:  Munirathinam Gnanasekar; Ramaswamy Kalyanasundaram; Guoxing Zheng; Aoshuang Chen; Maarten C Bosland; André Kajdacsy-Balla
Journal:  Prostate Cancer       Date:  2013-05-12

4.  Use of recombinant human soluble thrombomodulin in patients with sepsis-induced disseminated intravascular coagulation after intestinal perforation.

Authors:  Takashi Tagami; Hiroki Matsui; Kiyohide Fushimi; Hideo Yasunaga
Journal:  Front Med (Lausanne)       Date:  2015-02-26

Review 5.  Integrin-Ligand Interactions in Inflammation, Cancer, and Metabolic Disease: Insights Into the Multifaceted Roles of an Emerging Ligand Irisin.

Authors:  Eun Jeong Park; Phyoe Kyawe Myint; Atsushi Ito; Michael G Appiah; Samuel Darkwah; Eiji Kawamoto; Motomu Shimaoka
Journal:  Front Cell Dev Biol       Date:  2020-10-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.